Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
CF Boehringer und Soehne GmbH
Original Assignee
Boehringer Mannheim GmbH
CF Boehringer und Soehne GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH, CF Boehringer und Soehne GmbHfiledCriticalBoehringer Mannheim GmbH
Publication of ES210273A1publicationCriticalpatent/ES210273A1/en
A procedure for obtaining substituted morpholines of the general formula where it represents a phenyl radical and a hydrogen atom or a phenyl or alcohol radical and a hydrogen atom or a phenyl radical characterized by adding substituted diethanolamines of the general formula to concentrated sulfuric acid having the meaning indicated above. (Machine-translation by Google Translate, not legally binding)
ES0210273A1953-03-251953-07-09A procedure for obtaining replaced morpholines (Machine-translation by Google Translate, not legally binding)
ExpiredES210273A1
(en)
Procedure for the preparation of new oxazolinic and tiazolinic derivatives with nematocide action (Machine-translation by Google Translate, not legally binding)